One Bio

One Bio

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://www.one.bio/

Last Round

Series A

Dec 12, 2024

Total Funding Raised

$43.8M

Momentum Score

50 /100

Company Overview

One Bio is a biotechnology company that develops naturally-derived oligosaccharides from plant fibers designed for food, agriculture, and biopharmaceutical applications to support microbiome health and immune function.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Circular Economy

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

functional ingredientsprebiotic fibersprebioticsupcycled ingredientsoligosaccharidesgut healthfood techmicrobiome modulationB2B ingredientstasteless ingredientsfood fortificationsoluble fiberfood upcyclingimmune supportGlycopediacircular economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

One Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

One Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 12, 2024
Series AApr 13, 2022
GrantDec 1, 2021
SeedNov 1, 2020

Key People

Founding team and executive leadership

Matt Barnard

Cofounder CEO

Founding Team

Julie Wurfel

COO

Executive Team

One Bio Investors

Notable investors and investment history

One Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

One Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about One Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersDavis, California
Employee Range46
Year Founded2019
Last FundingDec 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.